Abstract |
The biological activities of tocotrienols are receiving increasing attention. Herein, we report the efficacy of a mixed- tocotrienol diet against prostate tumorigenesis in the transgenic adenocarcinoma mouse prostate (TRAMP) mouse model. Male TRAMP mice, 8 wk old, were fed 0.1%, 0.3%, or 1% mixed tocotrienols in AIN-76A diet up to 24 wk old. Likewise, a positive control group consisting of male TRAMP mice and a negative control group consisting of wild-type nontransgenic mice were fed regular AIN-76A diet up to 24 wk old. Our results show that mixed- tocotrienol-fed groups had a lower incidence of tumor formation along with a significant reduction in the average wet weight of genitourinary apparatus. Furthermore, mixed tocotrienols significantly reduced the levels of high-grade neoplastic lesions as compared to the positive controls. This decrease in levels of high-grade neoplastic lesions was found to be associated with increased expression of proapoptotic proteins BAD (Bcl(2) antagonist of cell death) and cleaved caspase-3 and cell cycle regulatory proteins cyclin dependent kinase inhibitors p21 and p27. In contrast, the expression of cyclins A and E were found to be decreased in mixed- tocotrienol groups. Taken together, our results show that by modulating cell cycle regulatory proteins and increasing expression of proapoptotic proteins, mixed tocotrienols suppress prostate tumorigenesis in the TRAMP mice.
|
Authors | Avantika Barve, Tin Oo Khor, Kenneth Reuhl, Bandaru Reddy, Harold Newmark, Ah-Ng Kong |
Journal | Nutrition and cancer
(Nutr Cancer)
Vol. 62
Issue 6
Pg. 789-94
( 2010)
ISSN: 1532-7914 [Electronic] United States |
PMID | 20661828
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anticarcinogenic Agents
- Tocotrienols
|
Topics |
- Adenocarcinoma
(prevention & control)
- Animals
- Anticarcinogenic Agents
(administration & dosage)
- Apoptosis
(drug effects)
- Cell Cycle
(drug effects)
- Disease Models, Animal
- Female
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Transgenic
- Prostatic Neoplasms
(prevention & control)
- Tocotrienols
(administration & dosage)
|